These results, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the strategy of focusing on ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Diseases. In response to this https://whatischronicpain85170.blog5star.com/32867774/conolidine-for-dummies